| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |